193 related articles for article (PubMed ID: 30619284)
1. TLR3 Activation of Hepatic Stellate Cell Line Suppresses HBV Replication in HepG2 Cells.
Zhang B; Liu Y; Wang X; Li J; Xu X; Guo L; Ho WZ
Front Immunol; 2018; 9():2921. PubMed ID: 30619284
[TBL] [Abstract][Full Text] [Related]
2. Retinoic acid inducible gene-I (RIG-I) signaling of hepatic stellate cells inhibits hepatitis C virus replication in hepatocytes.
Wang Y; Ye L; Wang X; Li J; Song L; Ho W
Innate Immun; 2013; 19(2):193-202. PubMed ID: 23060457
[TBL] [Abstract][Full Text] [Related]
3. Induction of interferon-λ contributes to Toll-like receptor-3-activated hepatic stellate cell-mediated hepatitis C virus inhibition in hepatocytes.
Wang Y; Li J; Wang X; Ye L; Zhou Y; Ho W
J Viral Hepat; 2013 Jun; 20(6):385-94. PubMed ID: 23647955
[TBL] [Abstract][Full Text] [Related]
4. Induction of interferon-λ contributes to TLR3 and RIG-I activation-mediated inhibition of herpes simplex virus type 2 replication in human cervical epithelial cells.
Zhou L; Li JL; Zhou Y; Liu JB; Zhuang K; Gao JF; Liu S; Sang M; Wu JG; Ho WZ
Mol Hum Reprod; 2015 Dec; 21(12):917-29. PubMed ID: 26502803
[TBL] [Abstract][Full Text] [Related]
5. Immune activation of human brain microvascular endothelial cells inhibits HIV replication in macrophages.
Li J; Wang Y; Wang X; Ye L; Zhou Y; Persidsky Y; Ho W
Blood; 2013 Apr; 121(15):2934-42. PubMed ID: 23401273
[TBL] [Abstract][Full Text] [Related]
6. Poly(I:C) treatment leads to interferon-dependent clearance of hepatitis B virus in a hydrodynamic injection mouse model.
Wu J; Huang S; Zhao X; Chen M; Lin Y; Xia Y; Sun C; Yang X; Wang J; Guo Y; Song J; Zhang E; Wang B; Zheng X; Schlaak JF; Lu M; Yang D
J Virol; 2014 Sep; 88(18):10421-31. PubMed ID: 24920792
[TBL] [Abstract][Full Text] [Related]
7. HBV Bypasses the Innate Immune Response and Does Not Protect HCV From Antiviral Activity of Interferon.
Mutz P; Metz P; Lempp FA; Bender S; Qu B; Schöneweis K; Seitz S; Tu T; Restuccia A; Frankish J; Dächert C; Schusser B; Koschny R; Polychronidis G; Schemmer P; Hoffmann K; Baumert TF; Binder M; Urban S; Bartenschlager R
Gastroenterology; 2018 May; 154(6):1791-1804.e22. PubMed ID: 29410097
[TBL] [Abstract][Full Text] [Related]
8. Interferon-stimulated gene of 20 kDa protein (ISG20) degrades RNA of hepatitis B virus to impede the replication of HBV in vitro and in vivo.
Leong CR; Funami K; Oshiumi H; Mengao D; Takaki H; Matsumoto M; Aly HH; Watashi K; Chayama K; Seya T
Oncotarget; 2016 Oct; 7(42):68179-68193. PubMed ID: 27626689
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B Virus Does Not Interfere With Innate Immune Responses in the Human Liver.
Suslov A; Boldanova T; Wang X; Wieland S; Heim MH
Gastroenterology; 2018 May; 154(6):1778-1790. PubMed ID: 29408639
[TBL] [Abstract][Full Text] [Related]
10. Human Cervical Epithelial Cells Release Antiviral Factors and Inhibit HIV Replication in Macrophages.
Xu XQ; Guo L; Wang X; Liu Y; Liu H; Zhou RH; Gu J; Liu JB; Xu P; Zhou L; Ho WZ
J Innate Immun; 2019; 11(1):29-40. PubMed ID: 30032138
[TBL] [Abstract][Full Text] [Related]
11. Immunostimulatory siRNA with a uridine bulge leads to potent inhibition of HBV and activation of innate immunity.
Lan T; Wei Z; He Y; Wan S; Liu L; Cheng B; Li R; Chen H; Liu G; Meng Z
Virol J; 2021 Feb; 18(1):37. PubMed ID: 33602251
[TBL] [Abstract][Full Text] [Related]
12. Toll-like receptor activated human and murine hepatic stellate cells are potent regulators of hepatitis C virus replication.
Wang B; Trippler M; Pei R; Lu M; Broering R; Gerken G; Schlaak JF
J Hepatol; 2009 Dec; 51(6):1037-45. PubMed ID: 19716616
[TBL] [Abstract][Full Text] [Related]
13. Hepatic stellate cells, liver innate immunity, and hepatitis C virus.
Wang Y; Li J; Wang X; Sang M; Ho W
J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1(0 1):112-5. PubMed ID: 23855305
[TBL] [Abstract][Full Text] [Related]
14. Human Intestinal Epithelial Cells Release Antiviral Factors That Inhibit HIV Infection of Macrophages.
Guo L; Xu XQ; Zhou L; Zhou RH; Wang X; Li JL; Liu JB; Liu H; Zhang B; Ho WZ
Front Immunol; 2018; 9():247. PubMed ID: 29515574
[TBL] [Abstract][Full Text] [Related]
15. Control of hepatitis B virus replication by interferons and Toll-like receptor signaling pathways.
Pei RJ; Chen XW; Lu MJ
World J Gastroenterol; 2014 Sep; 20(33):11618-29. PubMed ID: 25206268
[TBL] [Abstract][Full Text] [Related]
16. (-)-Epigallocatechin-3-gallate enhances poly I:C-induced interferon-λ1 production and inhibits hepatitis C virus replication in hepatocytes.
Wang YZ; Li JL; Wang X; Zhang T; Ho WZ
World J Gastroenterol; 2017 Aug; 23(32):5895-5903. PubMed ID: 28932081
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice.
Wu J; Lu M; Meng Z; Trippler M; Broering R; Szczeponek A; Krux F; Dittmer U; Roggendorf M; Gerken G; Schlaak JF
Hepatology; 2007 Dec; 46(6):1769-78. PubMed ID: 17929296
[TBL] [Abstract][Full Text] [Related]
18. Control of hepatitis B virus replication by innate response of HepaRG cells.
Lucifora J; Durantel D; Testoni B; Hantz O; Levrero M; Zoulim F
Hepatology; 2010 Jan; 51(1):63-72. PubMed ID: 19877170
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus polymerase inhibits RIG-I- and Toll-like receptor 3-mediated beta interferon induction in human hepatocytes through interference with interferon regulatory factor 3 activation and dampening of the interaction between TBK1/IKKepsilon and DDX3.
Yu S; Chen J; Wu M; Chen H; Kato N; Yuan Z
J Gen Virol; 2010 Aug; 91(Pt 8):2080-2090. PubMed ID: 20375222
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus impairs TLR3 signaling and inhibits IFN-λ 1 expression in human hepatoma cell line.
Wang Y; Li J; Wang X; Ye L; Zhou Y; Thomas RM; Ho W
Innate Immun; 2014 Jan; 20(1):3-11. PubMed ID: 23529855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]